Holdings derived from the most recent reported transactions. Not adjusted for stock splits or share-class conversions.
| Issuer | Shares | Source | Last tx | Detail |
|---|---|---|---|---|
| Aptose Biosciences Inc. | 55,000 | reported | 05 Feb 2024 | tx 5+1,365,000 |
| GYRE THERAPEUTICS, INC. | 3,744 | reported | 12 Aug 2019 | tx 18+345,433−1,562 |
| Date | Type | Issuer | Qty | Price | Signals |
|---|---|---|---|---|---|
| 05 Feb 2024 | GRANT_AWARD | Aptose Biosciences Inc. | 55,000 | 0.00 USD | deriv |
| 19 Jan 2023 | GRANT_AWARD | Aptose Biosciences Inc. | 100,000 | 0.00 USD | |
| 19 Jan 2023 | GRANT_AWARD | Aptose Biosciences Inc. | 200,000 | 0.00 USD | deriv |
| 19 Sept 2022 | PURCHASE | Aptose Biosciences Inc. | 10,000 | 0.68 USD | first after silence |
| 27 Jun 2022 | GRANT_AWARD | Aptose Biosciences Inc. | 1,000,000 | 0.00 USD | deriv |
| 12 Aug 2019 | GRANT_AWARD | GYRE THERAPEUTICS, INC. | 1,180 | 6.51 USD | |
| 11 Feb 2019 | GRANT_AWARD | GYRE THERAPEUTICS, INC. | 1,002 | 7.04 USD | |
| 04 Feb 2019 | EXERCISE | GYRE THERAPEUTICS, INC. | 1,503 | 4.63 USD | |
| 04 Feb 2019 | EXERCISE | GYRE THERAPEUTICS, INC. | 1,503 | 0.00 USD | deriv |
| 24 Jan 2019 | GRANT_AWARD | GYRE THERAPEUTICS, INC. | 38,000 | 0.00 USD | deriv |
| 30 Jul 2018 | GRANT_AWARD | GYRE THERAPEUTICS, INC. | 25,000 | 0.00 USD | deriv |
| 26 Mar 2018 | EXERCISE | GYRE THERAPEUTICS, INC. | 59 | 4.63 USD | |
| 26 Mar 2018 | EXERCISE | GYRE THERAPEUTICS, INC. | 59 | 0.00 USD | deriv |
| 12 Jan 2018 | GRANT_AWARD | GYRE THERAPEUTICS, INC. | 26,000 | 0.00 USD | deriv |
| 11 Jul 2017 | GRANT_AWARD | GYRE THERAPEUTICS, INC. | 75,000 | 0.00 USD | deriv |
| 17 Dec 2015 | PURCHASE | GYRE THERAPEUTICS, INC. | 10,000 | 2.00 USD | |
| 22 Oct 2015 | GRANT_AWARD | GYRE THERAPEUTICS, INC. | 28,572 | 0.00 USD | deriv |
| 22 Oct 2015 | GRANT_AWARD | GYRE THERAPEUTICS, INC. | 71,428 | 0.00 USD | deriv |
| 20 Aug 2015 | OTHER | GYRE THERAPEUTICS, INC. | 15,032 | — | |
| 20 Aug 2015 | OTHER | GYRE THERAPEUTICS, INC. | 14,325 | — | deriv |
| 20 Aug 2015 | OTHER | GYRE THERAPEUTICS, INC. | 2,440 | — | deriv |
| 20 Aug 2015 | OTHER | GYRE THERAPEUTICS, INC. | 7,320 | — | deriv |
1 purchase reported after at least 12 months of silence — most recent on 19 Sept 2022.